Transcriptional Age Deviation

Biomarker

1 paper3 findings

  • Humans1

Associations

3

Therapy resistance

upin humans1

1 study
  1. Transcriptional Age Deviation is associated with therapy resistance in humans.

    “Low TAD was associated with high-risk genetics and therapy resistance”

    HumansLow Transcriptional Age Deviation in acute myeloid leukemia

    A stem cell aging clock links biological age deviation to clinical outcome in acute myeloid leukemia

    bioRxiv (Cold Spring Harbor Laboratory)13 Feb 2026Preprint

High-risk genetics

upin humans1

1 study
  1. Transcriptional Age Deviation is associated with high-risk genetics in humans.

    “Low TAD was associated with high-risk genetics and therapy resistance”

    HumansLow Transcriptional Age Deviation in acute myeloid leukemia

    A stem cell aging clock links biological age deviation to clinical outcome in acute myeloid leukemia

    bioRxiv (Cold Spring Harbor Laboratory)13 Feb 2026Preprint

Survival

downin humans1

1 study
  1. Transcriptional Age Deviation predicts survival in humans.

    “a biologically “younger” state (low TAD), reflecting oncofetal reprogramming, is a powerful independent predictor of poor survival in two large AML cohorts.”

    HumansLow Transcriptional Age Deviation in acute myeloid leukemia

    A stem cell aging clock links biological age deviation to clinical outcome in acute myeloid leukemia

    bioRxiv (Cold Spring Harbor Laboratory)13 Feb 2026Preprint

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months